The high affinity of 4sCa binding to the low density lipoprotein receptor (LDL-R) and the LDL-R-related protein (LRP) was utilized to study the subcellular distribution of these two proteins in rat liver. Like the LDL-R, LRP was manyfold enriched in rat liver endosomal membranes with a relative distribution in early and late endosomal compartments consistent with recycling between endosomes and the cell surface. The high concentration of LRP in hepatic endosomal membranes greatly facilitated demonstration of Ca-dependent binding of apolipoprotein E-and B-containing Upoproteins in ligand blots. LRP was severalfold more abundant than the LDL-R in hepatic parenchymal cells, showed extensive degradation in hepatic endosomes, and was found in high concentrations in the Golgi apparatus and endoplasmic reticulum. These data suggest a high rate of synthesis of LRP that appeared to be unaffected by treatment of rats with estradiol. The repeating cysteine-rich A-motif found in the ligandbinding domain of LRP appeared to be responsible for Ca binding by LRP, LDL-R, and complement factor C9 and accounted for immunological cross-reactivity among these proteins. Weaker ligand-blotting properties and an extraordinary susceptibility to proteolysis most likely contribute to the difficulty of detecting LRP in conventional assays for lipoprotein receptors. Our data suggest an extensive proteolytic processing of this protein and are consistent with a functional role of LRP in lipoprotein metabolism.
LDL-R in hepatic parenchymal cells, showed extensive degradation in hepatic endosomes, and was found in high concentrations in the Golgi apparatus and endoplasmic reticulum. These data suggest a high rate of synthesis of LRP that appeared to be unaffected by treatment of rats with estradiol. The repeating cysteine-rich A-motif found in the ligandbinding domain of LRP appeared to be responsible for Ca binding by LRP, LDL-R, and complement factor C9 and accounted for immunological cross-reactivity among these proteins. Weaker ligand-blotting properties and an extraordinary susceptibility to proteolysis most likely contribute to the difficulty of detecting LRP in conventional assays for lipoprotein receptors. Our data suggest an extensive proteolytic processing of this protein and are consistent with a functional role of LRP in lipoprotein metabolism.
The complete amino acid sequence of a cell surface Cabinding protein with a striking homology to the low density lipoprotein receptor (LDL-R) was reported by Herz et al. (1) . The extracellular domain of this LDL-R-related protein (LRP) contains 31 copies of the negatively charged cysteinerich "class A-motif' also found in the LDL-R and the terminal complement factors. This repeating motif is clustered in four distinct regions in LRP extending from the amino-terminal end of the protein; thus the motif resembles four copies of the ligand-binding domain of the LDL-R. The A-motif closest to the amino terminus of the LDL-R has been shown to bind Ca (2) .
Based on the structural resemblance between the ligandbinding domain of the LDL-R and the repeating clusters of class A-motifs in LRP, a lipoprotein receptor function of LRP was suggested by Herz et al. (1) . The structural evidence for a role of LRP as a lipoprotein receptor is further strengthened by the finding, in the cytoplasmic tail of LRP, of two copies of the short amino acid sequence known to direct the LDL-R to coated pits (3) , thus suggesting that LRP may be internalized through endocytosis.
Two additional repeating structural elements are found in the extracellular portion of LRP. Regions homologous to the epidermal growth factor precursor are interspersed between the four regions of clustered A-motifs (1) , and a proline-rich potential cleavage site precedes six repeating regions homologous to the epidermal growth factor precursor near the membrane-spanning region of the protein. The terminus of these repeats in LRP is found at the exact same position, relative to the membrane-spanning region, as the released growth factor in the epidermal growth factor precursor.
We have utilized the high 45Ca-binding capacity of LRP and LDL-R to study the relative distribution of these two proteins in subcellular fractions of rat liver. Membranes prepared from hepatic endosomal and biosynthetic compartments proved to be highly enriched in LRP and thus particularly valuable for the initial characterization of its Ca-binding, lipoprotein-binding, and immunological properties.
MATERIALS AND METHODS Preparation of Lipoprotein Fractions. Low density lipoprotein (LDL) and high density lipoproteins from human, rat, and rabbit serum were isolated by sequential ultracentrifugation (4). Apolipoprotein (apo) E-poor fractions of these lipoproteins were prepared by species-specific anti-apoE affinity chromatography (5) . , ( very low density lipoproteins (J3-VLDL) were prepared from serum of rabbits fed a diet containing 1% cholesterol for 6-8 weeks (5). Large and small rat chylomicrons were prepared from intestinal lymph (6) . Chylomicron remnants were prepared in vivo from functionally eviscerated rats (7) or in vitro by incubation of chylomicrons with the density >1.019 g/ml plasma fraction obtained after injection of heparin (8) . Human apoE-containing unilamellar L-dimyristoyl lecithin recombinants (E-disks) were prepared as described (9) . Lipoproteins and E-disks were labeled with 125I by the iodine monochloride method (10) .
Isolation of Cells and Subcellular Fractions. Three endosomal fractions and membrane preparations thereof were isolated from liver of estradiol-treated rats after intravenous injection of LDL (11) and from the liver of untreated rats after injection of f3-VLDL (S. Jackle, R.L.H., and R.J.H., unpublished data).
Intact Golgi and rough endoplasmic reticulum (ER) fractions (12), lysosomal membranes (13), plasma membranes (14) , intact hepatocytes (15) , and crude membranes from both whole rat liver and hepatocytes (16) were prepared as described.
Type II cells (17) , fibroblasts, alveolar macrophages, and whole homogenate, microsomes, and mitochondrial membranes were prepared from rat lung as described (18 
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SDS/Gel Electrophoresis. Cellular and membrane proteins were routinely separated on 3-1o continuous polyacrylamide gradient gels and electrophoresed for 18-20 hr at 6 mA per gel. Gels were stained with Coomassie blue, silver, or periodic acid-Schiff reagent (19) . Proteins were transferred to nitrocellulose sheets at 200 mA for 20-24 hr (20) .
Blotting Procedures. Ligand blotting with 45Ca was performed on nitrocellulose sheets as described by Maruyama et al. (21) . 45Ca was occasionally removed from subsequent immunoblotting by washing for 18-20 hr with 20 mM CaCl2 in 15 mM Tris*HCI/20%o (vol/vol) ethanol, pH 5.0, with three or four changes of the wash solution. Lipoprotein blotting and immunoblotting were performed as described (22, 23) .
Preparation of Antibodies. A New Zealand White rabbit was immunized with three injections of 500 ,ug of endosomal membrane protein from an estradiol-treated rat in Freund's complete adjuvant. Polyclonal antibodies present in the antiserum against LRP and LDL-Rs were subsequently isolated by immunoabsorption as described by Olmsted (24) and modified by Coudrier et al. (25) . LRP and LDL-R, separated by SDS/PAGE and precisely localized by Ca blotting, were excised from the nitrocellulose sheets and used as absorbants. The anti-LRP solution was further purified by immunoabsorption three times with LDL-R and human and rat apoB immobilized on nitrocellulose sheets to obtain a monospecific antibody against LRP.
A polyclonal rabbit antiserum raised against a synthetic peptide of the carboxyl-terminal 13-amino acid tail of LRP and a monoclonal antibody directed against the carboxylterminal 20-amino acid tail of the human LDL-R (4A4MAb) were obtained from J. Herz and Y. K. Ho (University of Texas Health Science Center at Dallas). Purified human complement factor C9 and antiserum against human C9 were obtained commercially (Calbiochem).
RESULTS
Enrichment of LRP and LDL-R in Endosomal Membranes. LRP and LDL-R monomer and dimer were readily visualized in endosomal and crude membranes from livers of estradioltreated rats by their ability to bind 45Ca (Fig. 1B) . In endosomal membranes essentially no other proteins were detected with this simple procedure. LRP was enriched -50-fold in endosomal membranes relative to crude membranes, some- what more than the LDL-R (Fig. 1B) . Only LRP was detected in endosomal membranes from untreated rats (Fig. 1A ). As shown in Fig. 2 , LRP was easily detected by direct protein staining with Coomassie blue and with the low-sensitivity periodic acid-Schiff stain. LRP was the only glycoprotein detected in the high molecular weight region. The LDL-R was barely detectable with conventional protein stains, unless membranes from estradiol-treated rats were used (data not shown), indicating that LRP is normally more abundant in endosomal membranes than the LDL-R and that LRP is a major endosomal glycoprotein.
Immunoreactivity of LRP. A monoclonal anti-LDL-R-tail antibody (4A4MAb) detected only two proteins corresponding to the LDL-R monomer and dimer observed in the Ca blots (Fig. 3 , lane 2). Affinity-purified polyclonal antibodies against LDL-R monomer, prepared by immunoabsorption from the crude endosomal membrane antiserum (lane 1), or similarly prepared with anti-LRP (data not shown), showed obvious cross-reactivity between LRP and the LDL-R. Further immunoabsorption of the LRP antibody with LDL-R immobilized on nitrocellulose yielded a preparation highly enriched in antibodies against LRP (lane 3).
To test whether homologous epitopes in the ligand-binding domain (A-motifs) could give rise to cross-reactivity, we tested the ability of a polyclonal antibody against human C9 to detect rat endosomal LRP and LDL-R. Polyclonal antibodies against synthetic peptides of the A-motif of complement factor C9 can detect the other terminal complement factors that contain homologous but not identical A-motifs (26) . The fact that LRP and LDL-R were detected by the C9 antibody (Fig. 3 , lane 6) suggests that the A-motifs found in LRP, LDL-R, and the terminal complement factors are sufficiently homologous to cause immunological crossreactivity with polyclonal antibodies.
Purified C9, which contains only one A-motif (27) , also strongly bound 45Ca (Fig. 3, lane 7) and showed detectable binding of discoidal complexes of apoE (results not shown). This observation suggests that the cysteine-rich A-motif may be the functional Ca-binding unit of proteins sharing this sequence.
Intrahepatic and Subcellular Localization of LRP. 45Ca blots performed with homogenates and crude membranes prepared from isolated hepatocytes showed that LRP is mainly localized to the parenchymal cells of rat liver (results not shown). Fig. 4 shows that the protein was also detectable in low Recycling and Proteolytic Processing of LRP. The distribution of LRP and LDL-R in three biochemically and ultrastructurally different endosomal fractions (11) was very similar (Fig. 5) . A low concentration of both proteins was found (Fig. 5A) . With the carboxyl-terminal tail antibody of LRP, almost all immunoreactivity was found in the region of 75-85 kDa, and only a small amount of a protein of high molecular mass, presumably representing intact LRP (>550 Da), was observed (Fig. SB) . A striking lack of 75-to 85-kDa immunoreactivity was observed with the afflinity-purified LRP antibody (Fig. SC) . These results suggest that both the high molecular mass form of LRP and the 75-to 85-kDa immunoreactive species are recycled to the cell surface analogous to the LDL-R. 45Ca blots and immunoblots with the affinity-purified anti-LRP or anti-C9 were superimposable (Fig. 3) , but a slight difference in apparent molecular mass between the 45Ca signal and the immunoblot signal with the LRP-tail antibody was observed in the Golgi fractions. When the blots were superimposed, the immunoblot signal (Fig. 4B) had mainly a slightly higher average molecular mass than the 45Ca signal (Fig. 4A ). This slight difference in mass was also evident when comparing the immunoblots of the two different anti-LRP antibodies in endosomal membranes: that with the LRP-tail antibody showed a higher mass (Fig. 5 B and C) .
These observations suggest that LRP in hepatic endosomes is extensively proteolyzed, consisting mainly of a membranebound 75-to 85-kDa fragment with the tail epitope but lacking most of the extracellular portion of the molecule with the Ca-binding activity. With the exception of lung macrophages, this small fragment appears to coexist with LRP in cells or membranes from subcellular structures (Fig. 6) Separation of proteins, 45Ca blotting (A), and immunoblotting (B)
were performed as described in Fig. 5 .
activity but apparently lacking the transmembrane portion and cytoplasmic tail ofLRP constitutes the main mass of LRP detected with the affinity-purified anti-endosomal LRP but not the tail antibodies. The amount of intact noncleaved LRP apparently is too low to be detected by the 45Ca-blotting technique. The failure of the endosomal LRP antibody to detect the 75-to 85-kDa fragment is, therefore, most likely explained by the fact that immunoabsorption from the endosomal antiserum to obtain the LRP antibodies was performed with an endosomal LRP fragment mostly lacking tail epitopes. If proteolytic cleavage of LRP occurs in the extracellular part of the molecule (1), it would follow that the Ca-binding form of LRP found in endosomal membranes is lacking the tail and the transmembrane region and should be released to the endosomal content. We, therefore, tested for 45Ca-binding activity in the endosomal content obtained after French pressure cell treatment of intact endosomes (Fig. 7 ).
An appreciable amount of the 45Ca-binding high molecular mass fragment of LRP was detected (about one-third of the total) in the endosomal content. A number of Ca-binding components of lower molecular mass were also present. These may be additional proteolytic fragments containing A motifs of LRP.
We interpret these findings to suggest that the Ca-binding extracellular portion of LRP is further degraded in the RRC proteins (30 gg) were separated by SDS/PAGE on 3-10o polyacrylamide gels under nonreducing conditions and transferred to nitrocellulose. The individual strips from a single gel were cut out and probed with the indicated 125I-labeled lipoproteins at 2 u.tg/ml (specific activities ranged from 400 to 3000 cpm/ng). LDL was obtained before (apoE+) and after (apoE-) removal of apoE by affinity chromatography. Chylo., chylomicrons; Remn., remnants.
content of the endosome after being separated from the membrane-bound part containing the cytoplasmic tail. Most of this high molecular mass extracellular fragment evidently remains attached to the endosomal membrane.
Lipoprotein-Binding Properties of LRP. Lipoprotein binding to LRP was readily detected in endosomal membranes, with a specificity similar to that of the LDL-R (Fig. 8) . Binding to LRP was detected for all apoE-and apoB-containing particles tested, including E-disks. High density lipoprotein particles isolated from humans and rats with or without apoE did not bind detectably to LRP or the LDL-R. Binding of lipoproteins was Ca-dependent and was abolished in the presence of 30 mM EDTA (data not shown). Rabbit LDL (Fig.  8 ) and rat LDL (Fig. 3) showed a particularly strong binding to LRP, the former even after apoE was almost completely removed by anti-apoE affinity chromatography. Binding of apoE-rich particles (f3-VLDL, and chylomicron remnants prepared either in vitro or in vivo) and chylomicrons to LRP was relatively much weaker than to the LDL-R.
Although .1-z 14 [4] [5] [6] [7] [8] [9] [10] [11] blots, Ca-dependent binding of several lipoproteins containing apoB or apoE was detected, but not high density lipoprotein containing apoE. Although LRP contains elements with strong homology to the LDL-R and is apparently more abundant, at least in rat liver, it remained undetected during earlier extensive studies of the biochemical properties of the LDL-R. A possible reason is that the intact protein sequenced by Herz et al. (1) is actually found only in very low concentration, if at all, on the cell surface. LRP may also exhibit a completely different affinity in lipoprotein-binding experiments in cells or membranes than that observed in ligand blots.
Our results suggest that several properties of LRP may contribute to the difficulty of its detection in conventional assays. (i) The structural elements in the presumed ligandbinding domain of LRP and that of the LDL-R (the cysteinerich A-motifs) appear to be sufficiently homologous to cause immunological cross-reactivity, at least in rat liver. By comparing the specificity of antibodies that recognize different domains in the LRP molecule, we have reached the conclusion that in rat hepatic endosomes and plasma membranes, only a fraction of the detected protein is full-length LRP. This suggests an extensive proteolytic cleavage of the protein in the endocytic pathway or even earlier. Degradation of LRP apparently produces a fragment that does not contain the transmembrane segment and the carboxyl-terminal signal sequence for coated-pit clustering and rapid endocytosis and thus probably lacks the "correct" orientation of the extracellular ligand-binding domain. In our endosome preparations this high molecular mass fragment remains largely membrane-attached and is thus easily detected using ligandblotting techniques. Such a fragment, however, may not exhibit high-affinity lipoprotein binding in vitro or in vivo. The apparently extensive fragmentation of LRP may explain in part our failure to detect it in an earlier study of the lipoprotein-binding properties ofendosomal membranes (28) .
The membrane-bound 75-to 85-kDa fragment detected with the LRP-tail antibody is found in high concentration in endosomal membranes and apparently only in cells containing LRP. As noted by Herz et al. (1) , several regions homologous to epidermal growth factor and the cytoplasmic signal for clustering in coated pits are found in this fragment(s). We found evidence for a "recycling" itinerary of this protein in the endosomal membrane, and its presence in isolated plasma membranes prepared with proteolytic inhibitors suggests that this fragment may in fact reach the cell surface. We cannot, however, exclude the possibility that fragmentation of LRP during preparation of plasma membranes can give rise to such a result.
In preliminary experiments we have localized the extracellular portion of LRP to the microvillous surface, endosomal membranes, and the Golgi compartment of rat hepatocytes by immunogold labeling of affinity-purified LRP antibody in cryothin sections (R.L.H., H.L., and R.J.H., unpublished results).
We have also, in a series of experiments using Ca blotting, ligand blotting, and immunoblotting, demonstrated LRP in high concentration in hepatic endosomes from normal and Watanabe heritable hyperlipidemic (WHHL) rabbits (K.T., H.L., and R.J.H., unpublished results). These findings are consistent with the hypothesis that LRP, if it is a lipoprotein receptor, is responsible for the normal uptake of chylomicron remnants in the WHHL rabbit (29) . We have found a similar Ca-binding protein in high concentration in livers from chickens, a species that lacks apoE (30) and does not deliver intestinally derived lipids through the lymphatic system but relies on direct portal vein presentation of "portomicrons" to the liver (31) . Definitive assignment of a role for this interesting protein in lipoprotein metabolism will require analysis of its function in vivo.
Note. After this work was completed, Kowal et al. (32) reported that rabbit VLDL enriched with apoE caused a significant stimulation of cholesterol oleate synthesis in cultured fibroblasts from a patient with a null mutation of the LDL-R gene. This stimulation was specifically inhibited by polyclonal antibody against intact rat LRP, consistent with a role for LRP in the endocytosis of lipoproteins enriched in apoE.
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